Integrative Health Solutions logoIntegrative HealthSOLUTIONS

Recovery & Repair

BPC‑157 / KPV / TB‑500

A three-peptide compounded protocol combining repair signaling with anti-inflammatory tripeptide support.

Woman resting calmly on a yoga mat in a bright room
Format
Combination vial — injectable
Price
$230 per vial
Route
Injectable
Evidence level
Preclinical
Regulatory status
Compounded
Testing
Recent Labs Recommended

Pricing reflects the compounded preparation and doctor review. Final therapy and dosing are determined only after your intake is reviewed.

The components

Understanding the three components

Preclinical evidence

BPC-157

Connective tissue repair, joint mobility, and gut healing support.

BPC-157 is a synthetic peptide derived from a sequence found in human gastric juice.

Research focus

  • Potential support for tendon, ligament, and soft tissue recovery
  • Explored within protocols addressing gut lining integrity
  • Commonly discussed for joint comfort and mobility

Important: Evidence comes mainly from cell and animal research; human outcomes are not established.

View BPC-157
Preclinical evidence

KPV

Anti-inflammatory tripeptide for gut health and immune modulation.

KPV is a three-amino-acid fragment (lysine-proline-valine) of alpha-melanocyte-stimulating hormone.

Research focus

  • Explored within gut-focused wellness protocols
  • Discussed for inflammatory skin concerns
  • Potential support for immune balance

Important: Evidence comes mainly from cell and animal research; human outcomes are not established.

View KPV
Preclinical evidence

TB-500

Systemic tissue repair, flexibility, and injury recovery support.

TB-500 is a synthetic peptide based on a region of thymosin beta-4, a naturally occurring protein present in most human cells.

Research focus

  • Potential support for whole-body tissue recovery
  • Explored for flexibility and range of motion
  • Commonly stacked with BPC-157 in repair protocols

Important: Evidence comes mainly from cell and animal research; human outcomes are not established.

View TB-500

How it works

How the combination is designed to work

This protocol adds KPV — an alpha-MSH-derived tripeptide studied for inflammatory modulation — to the BPC-157 and TB-500 pairing, and is generally considered when gut and inflammatory concerns accompany a recovery goal.

  1. 01KPV has been investigated for its effect on inflammatory signaling in epithelial tissue, while BPC-157 and TB-500 research focuses on repair, angiogenesis, and cell migration.
Show illustration: BPC-157 / KPV / TB-500
BPC-157 / KPV / TB-500: proposed mechanism, physiology, and reported clinical effects. Educational illustration — not a treatment guarantee.

What has been studied

Potential applications and evidence

These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.

Explored where recovery and inflammatory symptoms overlap
Discussed within gut-focused wellness protocols
Potential support for soft tissue and joint comfort
Consolidates three peptides into one preparation

Doctor-guided

A personalized approach

Your doctor determines the final testing requirements for BPC-157 / KPV / TB-500 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.

Bloodwork status: Recent Labs Recommended

Commonly reviewed at baseline

  • CBC
  • Comprehensive metabolic panel (CMP)
  • hs-CRP
  • Vitamin D
  • Ferritin

Follow-up & monitoring

Inflammatory markers such as hs-CRP may be rechecked at 8 to 12 weeks when they were elevated at baseline.

Medication review

Your doctor reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.

Format & dosing

Typically a daily subcutaneous injection. Your doctor may recommend a defined cycle followed by reassessment.

Safety

What patients should know

  • Compounded medication, not an FDA-approved product. Not appropriate with active malignancy. Full medication and condition review required at intake.

Who may not be a candidate

  • Pregnancy or nursing
  • Active malignancy without oncology clearance
  • Known hypersensitivity to the preparation

Regulatory status: Compounded. Evidence level: Preclinical. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed doctor after review of your history.

Common questions

Frequently asked questions

Ready when you are

Find out what your body is actually asking for.

Fill out a short intake form and our care team will build a plan grounded in your labs — not a guess from a supplement aisle.